首页> 外国专利> Novel crystals of 5-(1Z, 2E) -2-methyl-3-phenyl-2-propenylidene -4-oxo-2-thioxo-3-thiazolidineacetic acid, a method for producing the same and a drug containing the crystal as an active ingredient

Novel crystals of 5-(1Z, 2E) -2-methyl-3-phenyl-2-propenylidene -4-oxo-2-thioxo-3-thiazolidineacetic acid, a method for producing the same and a drug containing the crystal as an active ingredient

机译:5-[(1Z,2E)-2-甲基-3-苯基-2-丙烯基] -4-氧代-2-硫代氧-3-噻唑烷乙酸的新型晶体,其制备方法和包含该晶体的药物作为有效成分

摘要

Kind Code: A1 The present invention provides a novel and uniform crystal of 5-[(1Z, 2E) -2-methyl-3-phenyl-2-propenylidene] -4-oxo-2-thioxo-3-thiazolidineacetic acid having excellent photostability. Provided are a production method and a drug containing the crystal as an active ingredient. SOLUTION: 5-[(1Z, 2E) -2-methyl-3-phenyl-2-propenylidene]-having at least one of the physicochemical data represented by the following A, B and C: Form A crystal of 4-oxo-2-thioxo-3-thiazolidineacetic acid, a method for producing the same, and a drug containing the same as an active ingredient: A: having a powder X-ray diffraction spectrum shown in FIG. 1 (selection diagram); B: Infrared absorption spectrum (IR) measured using the reflection method is shown in FIG. 2; C: Differential scanning calorimetry (DSC) result is shown in FIG. [Selection diagram] Fig. 1
机译:本发明提供了新颖且均匀的5-[(1Z,2E)-2-甲基-3-苯基-3-丙烯-2-丙烯基] -4-氧代-2-硫代氧代-3-噻唑烷乙酸的晶体。光稳定性。提供一种含有该晶体作为有效成分的制造方法和药物。解决方案:5-[(1Z,2E)-2-甲基-3-苯基-2-丙烯基]-至少具有一种由以下A,B和C表示的理化数据:4-氧- 2-硫代氧杂-3-噻唑烷乙酸,其制造方法以及含有其作为有效成分的药物:A:具有图1所示的粉末X射线衍射光谱。 1(选择图); B:使用反射法测量的红外吸收光谱(IR)示于图2。 2; C:差示扫描量热法(DSC)结果示于图2。 [选择图]图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号